Finally, after decades, immune checkpoint inhibitors dethroned the standard of care of small-cell lung cancer.

Subjects

Subjects :

B7-H1 Antigen antagonists & inhibitors
Humans
Lung Neoplasms immunology
Neoplasm Staging
Programmed Cell Death 1 Receptor antagonists & inhibitors
Small Cell Lung Carcinoma immunology
Standard of Care
Antineoplastic Agents, Immunological therapeutic use
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Immunotherapy methods
Lung Neoplasms therapy
Small Cell Lung Carcinoma therapy

Details

Language :

English

ISSN :

1750-7448

Volume :

11

Issue :

6

Database :

MEDLINE

Journal :

Immunotherapy

Publication Type :

Editorial & Opinion

Accession number :

30860440

Full Text :

https://doi.org/10.2217/imt-2019-0010